Interestingly, in TMA, we found that CCR5 and CCL5 were both expressed at high levels in PC that are moderately and poorly differentiated, and which were in contrast when similar characterization was made in non-neoplastic PC tissues that expressed CCR5 and CCL5 in low levels. This evidence concerns the gene CCR5 and pachyonychia congenita.